These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 15524016

  • 1. [Pharmacoeconomics of asthma].
    Jahnz-Rózyk K, Targowski T.
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():48-9. PubMed ID: 15524016
    [Abstract] [Full Text] [Related]

  • 2. [Introduction to asthma and chronic obstructive pulmonary disease pharmacoeconomics].
    Jahnz-Rózyk K.
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():5-6, 8. PubMed ID: 15524004
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The pharmacoeconomics of asthma].
    Plaza Moral V.
    Arch Bronconeumol; 1999 May; 35 Suppl 3():22-6. PubMed ID: 10410220
    [No Abstract] [Full Text] [Related]

  • 5. [Pharmacoeconomic aspects of bronchial asthma].
    Prosekova EV, Gel'tser BI, Shestovskaia TN.
    Ter Arkh; 2000 May; 72(3):55-8. PubMed ID: 10776656
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Response to Campbell, Spackman, Sullivan letter to Allergy.
    Brown R, Turk F, Dale P, Bousquet J.
    Allergy; 2008 Jun; 63(6):783. PubMed ID: 18445194
    [No Abstract] [Full Text] [Related]

  • 10. [Analyzing the economy, something is changing concerning asthma].
    Serra Batlles J.
    Arch Bronconeumol; 2009 Oct; 45(10):475-7. PubMed ID: 19758739
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.
    Sullivan SD, Turk F.
    Allergy; 2008 Jun; 63(6):670-84. PubMed ID: 18445184
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care.
    Arnlind MH, Nokela M, Rehnberg C, Jonsson EW.
    J Asthma; 2006 Oct; 43(8):585-91. PubMed ID: 17050222
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II).
    Sullivan SD, Lee TA, Blough DK, Finkelstein JA, Lozano P, Inui TS, Fuhlbrigge AL, Carey VJ, Wagner E, Weiss KB.
    Arch Pediatr Adolesc Med; 2005 May; 159(5):428-34. PubMed ID: 15867115
    [Abstract] [Full Text] [Related]

  • 18. Cost effectiveness of asthma controller therapies: influence of disease severity and other variables.
    Navarro RP, Parasuraman B.
    Manag Care Interface; 2005 Jun; 18(6):31-40. PubMed ID: 16018297
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.